Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus

American Journal of Pathology

Volumn 154, Issue 4, 1999, Pages 965-973

  Jankowski, Janusz A ^a,b   Wright, Nick A ^b   Meltzer, Stephen J ^c   Triadafilopoulos, George ^d   Geboes, Karl ^e   Casson, Alan G ^f   Kerr, David ^a   Young, Lawrence S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CATENIN; CELL ADHESION MOLECULE; EPIDERMAL GROWTH FACTOR; PROTEIN P16; PROTEIN P53;

ADENOCARCINOMA; ANEUPLOIDY; APOPTOSIS; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CIGARETTE SMOKING; DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS CARCINOMA; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC STABILITY; GOBLET CELL; HEARTBURN; HISTOPATHOLOGY; HUMAN; LOWER ESOPHAGUS SPHINCTER; METAPLASIA; METHYLATION; MOLECULAR EVOLUTION; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REFLUX ESOPHAGITIS; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 0032954422     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65346-1     Document Type: Review

References (84)

1. Spechler SJ: Barrett's esophagus. Sem Oncol 1994, 21:431-437
2. Winter C Jr, Spurling TJ, Chobabian SJ, Curtis DJ, Esposito RL, Hacker JF III, Johnston DA, Cruess DF, Cotelingam JD, Gurney MS, Cattau EL Jr: Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987, 92: 118-124
3. Prach AT, MacDonald TA, Hopwood DA, Johnston DA: Increasing incidence of Barrett's oesophagus: education, enthusiasm or epidemiology. Lancet 1997, 350:933
4. Beynon J, Pye JK, Howell P, Nehra D: Assessment of combined bile acid and pH profiles using an automated sampling device in gastrooesophageal reflux disease. Br J Surg 1998, 85:134-137
5. Romero Y, Cameron AJ, Locke GR, Schaid DJ, Melton LJ, Slexak J: Familial gastroesophageal reflux: association with Barrett's esophagus and adenocarcinoma. Gastroenterology 1997, 110:456
6. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK: Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994, 344:1533-1536
7. Johnston MH, Hammond AS, Laskin W, Jones DM: The prevalence and clinical characteristics of short segments of specialised intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996, 91:1507-1511
8. Cameron AJ, Lomboy CT: Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992, 103:1241-1245
9. Chalasani N, Wo JM, Hunter JG, Waring JP: Significance of intestinal metaplasia in different areas of esophagus including the esophago-gastric junction. Dig Dis Sci 1997, 42:603-607
10. Morales TG, Bhattacharyya A, Johnson C, Sampliner RE: Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia? Am J Gastroenterol 1997, 92:1818-1822
11. Kim R, Weissfeld JL, Reynolds JC, Keller LH: Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidem Biomarkers Prevent 1997, 6:369-377
12. Powell J, McConkey CE: The rising trend in oesophageal adenocarcinoma and gastric cardia cancer. Eur J Cancer Prev 1992, 1:265-269
13. Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F: Surgical pathology of arising in Barrett's-esophagus: analysis of 67 cases. Am J Surg Pathol 1995, 19:183-191
14. Das KM, Prasad I, Garla S, Amenta PS: Detection of a shared colon epithelial epitope on Barrett's epithelium by a novel monoclonal antibody. Ann Int Med 1994, 120:753-756
15. Tuyns AJ: Oesophageal cancer in France and Switzerland: recent time trends. Eur J Cancer Prev 1992, 1:275-278
16. Day NE, Munoz N, Ghadirian P: Epidemiology of esophageal cancer: a review. Epidemiology of Cancer of the Digestive Tract. Edited by P Correa and W Haenszel. Martinus Nijhoff, The Hague, 1982, pp 21-57
17. Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG, Liff JM, Fraumeni JF, Hoover RN: Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995, 87:1104-1109
18. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF: Rising incidence of adenocacinoma of the esophagus and gastric cardia. J Am Med Asso 1993, 265:1287-1289
19. Barr H, Shepherd NA, Dix A, Roberts DJH, Tan WC, Krasner N: Eradication of high grade dysplasia in columnar-lined esophagus by photodynamic therapy with endogenously generated photoporphyrin-IX. Lancet 1996, 348:584-585
20. Sagar PM, Ackroyd R, Hosie KB, Patterson JE, Stoddard CJ, Kingsnorth AN: Regression and progression of Barrett's oesophagus after antireflux surgery. Br J Surg 1995, 82:806-810
21. Provenzale D, Kemp JA, Arora S, Wong JB: A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994, 89: 670-680
22. Streitz JM, Andrews CW, Ellis FH: Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993, 105:383-387
23. Fearon E, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767
24. Weinstein WM, Ippoliti AF: The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc 1996, 44:91-94
25. Mason RJ, Bremner CG: Gastritis in Barrett's esophagus. World J Surg 1995, 19:96-101
26. Jankowski J, Coghill G, Hopwood D, Wormsley K: Oncogenes and anti-oncogenes in adenocarcinoma of the oesophagus. Gut 1992, 33:1033-1038
27. Brito M, Filipe MI, Linehan J, Jankowski J: Transforming growth factor α expression in gastro-oesophageal tumorigenesis may reflect altered processing of the precusor peptide. Int J Cancer 1995, 60: 27-32
28. Blount PL, Galipeau PC, Sanchez CA, Neshat K, Levine DS, Yin J, Suzuki H, Abraham JM, Meltzer SJ: Analyses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res 1994, 54:2292-2295
29. Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ, Raid BJ, Blount PL, Meltzer SJ, Yin J, Huang Y, Krasna MJ, Reid BJ: Clonal ordering of 17p and 5q allelic losses in Barrett's dysplasia and adenocarcinoma. Proc Natl Acad Sci USA 1993, 90:3221-3225
30. Jankowski J, Austin W, Howat K, Coghill G, Dover R, Hopwood D, Wormsley K: Proliferating cell nuclear antigen labelling in the oesophagus; correlation with autoradiography. Eur J Gastroenterol Hepatol 1992, 4:579-584
31. Boynton RF, Blount PL, Yin J, Brown VL, Huang Y, Tong Y, McDaniel T, Newkirk C, Resau JH, Raskind WH, Haggitt RC, Reid BJ, Meltzer SJ: Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci USA 1992, 89:3385-3388
32. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer SJ: Loss of heterozygosity involves multiple tumour suppressor genes in human esophageal cancers. Cancer Res 1992, 52:6525-6530
33. Reid BJ, Sanchez CA, Blount PL, Levine DS: Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993, 105:119-129
34. Bailey T, Biddleston L, Shepherd N, Barr H, Warner P, Jankowski J: Altered cadherin/catenin complexes in the dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 1998, 152:135-144
35. Spechler SJ, Goyal RK: The columnar-lined esophagus, intestinal metaplasia and Norman Barrett. Gastroenterology 1996, 110:6114-6621
36. Hopwood D, Milne G, Bouchier I: Effect of bile acids and hydrogen ions on the fine ultrastructure of the oesophageal epithelium. Gut 1981, 22:305-311
37. Tobey NA, Orlando RC: Mechanisms of acid injury to rabbit esophageal epithelium. Gastroenterology 1991, 101:1220-1228
38. Kaver WKH, Peters JH, Demeester TR, Ireland AP, Bremner CG, Hagen JA: Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone: the need for surgical therapy re-emphasised. Ann Surg 1995, 222:525-533
39. Vaezi MF, Richter JE: Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995, 108:1897-1907
40. Jankowski J: Gene expression in Barrett's mucosa: modulation of acute and chronic adaptive respones. Gut 1993, 34:1012-1014
41. Hanby A, Jankowski J, Elia G, Poulsom R, Wright NA: Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium differentiates secretory lineages. J Pathol 1994, 168:210-216
42. Jankowski J, Wright NA: Epithelial stem cells in the gastrointestinal tract: structure, function and adaptation. Sem Cell Biol 1992, 3:445-456
43. Shields HM, Sawhney RA, Zwas F, Boch JA, Kim S, Goran D, Antonioli DA: Scanning electron microscopy of the human esophagus: application to Barrett's esophagus, a precancerous lesion. Microsc Res Tech 1995, 31:248-256
44. Boch JA, Shields HM, Antonioli DA, Zwas F, Sawhney RA, Trier JS: Distribution of cytokeratin markers in Barrett's specialised columnar epithelium. Gastroenterology 1997, 112:760-765
45. Patel HR, Hewer A, Phillips DH, Hayes JD, Wolf CR, Campbell FC: Metabolic competence and susceptibility of intestinal epithelium to genotoxic injury during regeneration. Carcinogenesis 1997, 18:2171-2177
46. MacKay CK, Stuart RC, Going J, Baxter JN, Keith WN: Interphase cytogenetics of non-dysplastic Barrett's esophagus. Gastroenterology 1997, 112:A607
47. Wu TT, Watanabe T, Heitmiller R, Zahurak M, Forastiere AA, Hamilton SR: Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 1998, 153:287-294
48. Wu GD, Beer DG, Moore JH, Orringer MB, Appelamn HD, Traber PG: Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma. Gastroenterology 1993, 105:837-844
49. Weston AP, Cherian R, Horum RT, Lawrinenko V, Dixon A, McGregor D: Mucosa associated lymphoid tissue (MALT) in Barrett's esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma and HLO's. Am J Gastroenterol 1997, 92: 800-804
50. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ: Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998, 58:2929-2934
51. Wright TA: High grade dysplasia in Barrett's metaplasia. Br J Surg 1997, 84:760-766
52. Altorki NK, Sunagawa M, Little AG, Skinner DB: High grade dysplasia in the columnar-lined esophagus. Am J Surg 1991, 161:97-99
53. Levine DS, Haggitt RC, Blount PL, Weinstein WM, Reid BR: An endoscopic biopsy protocol can differentiate high grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1995, 105:40-50
54. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS: Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992, 102:1212-1219
55. Coppola D, Falcone R, Livingston S, Karl R, Nicosia S, Cacho CM: Cyclin D1 expression correlates with degrees of dysplasia in Barrett's esophagus. Lab Invest 1997, 76:298-302
56. Morales CP, Lee EL, Shay JW: In situ hybridisation for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer 1998, 83:652-659
57. Wong DJ, Barrett MT, Stoger R, Emond MJ, Reid BJ: p16 (ink4) promoter is hypermethylated at a high frequency in esophageal adenocarcinoma. Cancer Res 1997, 57:2619-2622
58. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS, Reid BJ: 17p (p53) allelic losses, 4N (G(2)/tetraploid) populations, and progression to aneuploidy in BE. Proc Natl Acad Sci USA 1996, 93:7081-7084
59. Neshat K, Sanchez CA, Galipeau PC, Blount PL, Levine DS, Joslyn G, Reid BJ: p53 mutations in Barrett's adenocarcinoma and high grade dysplasia. Gastroenterology 1994, 106:1589-1595
60. Casson AG, Mukhopadhay T, Cleary KR, Ro JY, Levin B, Roth JA: p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 1991, 51:4495-4499
61. Younes M, Lebovitz RM, Lechago LV, Lechago J: p53 protein accumulation in Barrett's metaplasia, dysplasia and carcinoma: a follow up study. Gastroenterology 1993, 105:1637-1642
62. Hamelin R, Flejou JF, Muzeau F, Potet F, Laurent-Purg P, Fekete F, Thomas G: TP53 mutations, and p53 protein immunoreactivity in malignant and premalignant Barrett's oesophagus. Gastroenterology 1994, 107:1012-1018
63. Katada N, Hinder RA, Smyrk TC, Hirabayashi N, Perdikis G, Lund RJ Woodward T, Klinger PJ: Apoptosis is inhibited ealy in the dysplasia-carcinoma sequence of Barrett's esophagus. Arch Surg 1997, 132: 728-732
64. Goldblum JR, Rice TW: Bcl-2 protein expression in Barrett's metaplasia, dysplasia carcinoma sequence. Mod Pathol 1995, 8:866-869
65. Fan XJ, Crowe SE, Bamford K, Van Houten N, Reyes VE, Ernst PB: Fas-mediated apoptosis of gastric epithelial cells. Gastroenterology 1997, 110:A13
66. Raskind WH, Norwood T, Levine DS, Haggitt RC, Rabinovitch PS, Reid BJ: Persistent clonal areas and clonal expansion in Barrett's esophagus. Cancer Res 1994, 52:2946-2950
67. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997, 275:1787-1790
68. Zhuang Z, Vortmeyer AD, Mark RJ, Odze R, Emmert-Buch MR, Merino MJ, Moen H, Liotta CA, Durage OH: Barrett's esophagus metaplastic cells with loss of heterozygosity at the APC gene loci are clonal precursors to invasive adenocarcinoma. Cancer Res 1996, 56:1961-1964
69. Powell S, Papadopoulos N, Kinzler KW, Smolinski K, Meltzer SJ: Truncating APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology 1994, 107:1759-1763
70. Jankowski J, Bruton R, Shepherd N, Sanders S: Catenin regulated transcription provides a global mechanism for cancer progression. Mol Pathol 1997, 50:1-3
71. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H: Depletion of epithelial stem cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998, 19:379-383
72. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512
73. Hsu SC, Galceran J, Grosschedl R: Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin. Mol Cell Biol 1998, 8:4807-4818
74. Jankowski J: Clonality of esophageal carcinomas: genetic and epigenetic events leading to loss of genomic stability. Dis Esophagus 1997, 10:143-144
75. Novelli MR, Williamson JA, Tomlinson IP, Elai G, Hodgson SV, Talbot IC, Bodmer WF, Wright NA: Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science 1996, 272:1187-1190
76. Montesano R, Hollstein M, Hainaut P: Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996, 69:225-235
77. Reid BJ, Barrett MT, Galipeau PC, Sanchez CA, Neskat K, Cowan DS, Levine DS: Barrett's esophagus: ordering the events that lead to cancer. Eur J Cancer Prevent 1996, 52:57-65
78. Dolan K, Garde J, Gosney J, Sissons M, Wright T, Kingsnorth AN, Walker SJ, Sutton R, Meltzer SJ, Field JK: Alleotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites. Br J Cancer 1998, 78:950-957
79. Aoki T, Mori T, Du X, Nishihira T, Marsbra T, Nakamura Y: Alleotype study of oesophageal cancer. Genes Chromosomes Cancer 1994, 10:177-182
80. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ: Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 1996, 12:1873-1878
81. Meltzer SJ, Yin J, Manin B, Rhyu MG, Cottrell J, Hudson E, Redd JL, Krasna MJ, Abraham JM, Reid BJ: Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's associated esophageal adenocarcinomas. Cancer Res 1994, 54:3379-3382
82. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL, Russell SH: Ubiquitous somatic alterations at microsatellite alleles occur infrequently in Barrett's associated esophageal adnocarcinoma. Cancer Res 1996, 56:259-26
83. Garrigue-Antar L, Souza RF, Vellucci VF, Meltzer SJ, Reiss M: Loss of transforming growth factor β type II receptor gene expression in human esophageal cancer. Lab Invest 1996, 75:263-272
84. Wang S, Souza RF, Kong D, Yin J, Smolinski KN, Zou TT, Frank T, Young J, Flanders KC, Sugimura H, Abraham JM, Meltzer SJ: Deficient transforming growth factor-β1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors. Cancer Res 1997, 57:2543-2546